A decrease of PDE4 isoforms has been shown in AD patients and the PDE4 inhibitor rolipram has demonstrated memory enhancements36 as well as displaying a good antidepressant effect but with unpleasant side effects38. Here, PDE4A is linked to Alzheimer disease.